Organization of gynaecological cancer care最新文献

{"title":"1117 Influence of COVID-19 pandemic on staging of ovarian cancer – experience of certified advanced ovarian cancer surgery center","authors":"J. Dobroch, I. Gronostajska, AK Strosznajder, K. Kubica, I. Lenartowicz, G. Naronowicz, P. Knapp","doi":"10.1136/ijgc-2021-esgo.329","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.329","url":null,"abstract":"Introduction/Background*COVID-19 pandemic restrictions caused a limitation in healthcare services availability. This could lead to the delay in diagnosis and onset of the treatment. Ovarian cancer (OC) is frequently detected in advanced stage due to its asymptomatic development. The study aimed to determine whether the incidence and staging of OC were influenced by COVID-19 pandemic in the certified advanced ovarian cancer surgery center.MethodologyThe study consisted of 77 patients with primary ovarian cancer admitted to the University Oncology Center in Białystok, Poland between march 2019 and march 2021. We divided patients into two groups, first one diagnosed prior to the pandemic (before march 2020), and the second – diagnosed during pandemic-associated restrictions period. Both groups were compared according to FIGO (International Federation of Gynaecology and Obstetrics) staging and presence of symptoms (hydrothorax and ascites). Statistical analysis was performed with logistic regression analysis. Statistical significance level was set at 0,05.Result(s)*Before the pandemic, 47 patients were admitted with a median age of 61. During the pandemic, there were 30 newly diagnosed patients with a median age of 59. In both groups the most common type of cancer was high grade serous adenocarcinoma (61,7% and 60,0%, respectively). Patients with an advanced OC (FIGO stage III and IV) accounted for 57,4% in the pre-pandemic group, while in the second group patients with advanced cancer accounted for 66,7%. Although the percentage was higher in the second group, the logistic regression analysis did not confirm the impact of pandemic on more frequent occurrence of FIGO III (p=0,17) and IV (p=0,81) diagnosis. Ascites was found in 29,8% of patients before and 30% during pandemic. Hydrothorax was observed in 14,9% of patients in the first group and 26,7% in the second one. Logistic regression analysis revealed no influence of pandemic on percentage of symptomatic patients (p=0,91 for ascites and p=0,18 for hydrothorax).Conclusion*The number of newly diagnosed OC patients was lower during the pandemic than in the preceding year. Without regard to healthcare availability, OC remains the disease which is diagnosed in the advanced stage.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126737039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"686 Impact of COVID pandemic in the diagnosis of endometrial and ovarian cancers","authors":"J. Sole-Sedeño, E. Miralpeix Rovira, S. Espuelas, J. Castella, B. Fabregó, A. Salvado, G. Mancebo","doi":"10.1136/ijgc-2021-esgo.314","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.314","url":null,"abstract":"Introduction/Background*The COVID pandemic has had the collateral effect of an alteration in the diagnosis and care of other diseases. In our center, a 30% decrease in the number of cancer diagnoses has been estimated. The objective of this study was to account for this variation in the area of gynecological oncology.MethodologyThe diagnoses of endometrial cancer and ovarian cancer, of any histology, diagnosed in our center between April 1, 2019 and March 31, 2021 were reviewed. Data were compared between the pre-COVID period (1/04/19-31/03/20) and COVID (01/04/20-31/03/21).Result(s)*The number of endometrial cancer diagnoses decreased from 33 to 25 cases (25% decrease). Grouped by stages, initial diagnoses (FIGO I/II) went from 72% to 64%, with an increase in advanced stages (FIGO III/IV) (27% to 36%).Regarding ovarian cancer, the number of diagnoses was similar (24 pre-COVID vs 26 COVID), although with a slight increase in advanced stages (58% pre-COVID vs 65%). Within the advanced ones, we observed a significant increase in their severity, being in COVID time all stages III (14 cases), while in COVID time 11.2% were IVA stages and 41.2% IVB.Conclusion*In neoplasms where the initial symptoms are mild, such as endometrial cancer, the number of cases has been reduced, which may be due to the lack of consultation by patients. Regarding ovarian cancer, we have not seen a decrease in cases, although we have seen an increase in the stage. It is expected that the consequences of the COVID pandemic will continue to be felt in the future with an increase in the advanced stages of these neoplasms.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"256 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129062635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"856 Audit to streamline multidisciplinary team meetings by implementing standard of care for early endometrial cancer cases","authors":"P. Bansal, F. Sefre","doi":"10.1136/ijgc-2021-esgo.321","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.321","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129235802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"818 Compliance with enhanced recovery after surgery in a gynaecological oncology service in the west of Ireland","authors":"C. O’Gorman, E. Loughnane, D. Zibar, L. O’Sullivan, Saiful Azman, K. Astbury, M. O'Leary","doi":"10.1136/ijgc-2021-esgo.320","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.320","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134253060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"883 Surgical oncology for non-COVID-19 patients during the pandemic","authors":"K. B. Ben Hamida, H. Bouaziz, A. Jellali, N. Tounsi, H. Bouzaiene, M. Hsairi, M. Slimane, K. Rahal","doi":"10.1136/ijgc-2021-esgo.322","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.322","url":null,"abstract":"Introduction/Background*The COVID-19 pandemic has turned the standard of care of medicine worldwide into a “public health emergency of international concern. “Cancer patients are a unique population in that they are vulnerable to COVID-19, particularly if immunocompromised, and also, their oncologic outcome is based on the type and timing of the treatment.MethodologyA retrospective review comparing all surgical activities between the year before COVID-19 and the year after.This study was conducted in the Surgical Oncology Department in Salah Azaiez Institute of Oncology, the reference cancer care center in Tunisia.Result(s)*In our center, we created a new surgical procedures team.There was a significant reduction in the median daily breast surgery, superficial surgery, and ambulatory surgery (< 0,001). But not all operation types decreasing in frequency.Three months after COVID -19, we selected patients for laparotomy and decreased our activity by 50%.Starting from June 2020, we have increased our activity to exceed that of 2019. No increase in mortality or morbidity from treatment during COVID-19 for operated patients.The total surgically consults volume decreased by 36,17% in the post-COVID-19 period, significantly reducing the median daily consult volume (p<0.001).Conclusion*In this new context, the decision for surgery is driven not only by what is best for the individual patient but also by the concern for transmitting COVID-19 to patients and health care workers.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133841944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"591 Perioperative care in gynaecological cancer surgery during the COVID pandemic in a low resource centre – role of enhanced recovery protocols","authors":"P. Rema, A. Nath, D. Dinesh, S. Ranjith J, S. Sambasivan","doi":"10.1136/ijgc-2021-esgo.308","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.308","url":null,"abstract":"Introduction/Background ∗ ERAS (Enhanced Recovery after Surgery) is a multimodal perioperative care pathway designed to achieve early recovery after surgical procedures. This study aimed to analyse the feasibility of ERAS in the era of pandemic and to find its effect on the post-operative outcome of patients undergoing surgery for gynaecological cancer during the COVID pandemic Methodology This observational study was done on patients who underwent gynaecological cancer surgery during COVID pandemic in a tertiary cancer centre in South India. Data was collected including patient demographics, nature of surgery, adherence to each of the components of ERAS programme and outcomes. Post operative complications were graded according to the Clavien-Dindo classification Result(s)∗ 152 patients were included in the study period from June to December 2020. 85 patients had cancer ovary, 59 cancer endometrium, 6 cancer cervix and 1 cancer vulva and 7 patients had benign tumours. In the pre operative component of ERAS protocols,82% patients received pre surgery counselling, 97% received thromboembolic prophylaxis, 94% received carbohydrate loading and none of the patients received mechanical bowel preparation. 8% received blood components during and after surgery. In the post operative phase on Day 1, 62% patients had urinary catheter removed, 88% received normal diet and 92% had early ambulation. The complication rate was 26%, but majority 79% had grade 1 and 2 complications. There was one postoperative mortality due to sepsis. The mean hospital stay was 6.6 days. Conclusion∗ The study confirms the feasibility and benefits of following ERAS pathway in enhancing patient recovery during COVID pandemic.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115439588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"1014 Is there a role for a multidisciplinary tumor board smart virtual assistant in locally advanced cervical carcinoma? A proof of concept","authors":"G. Macchia, G. Ferrandina, S. Patarnello, R. Autorino, C. Masciocchi, V. Pisapia, C. Calvani, C. Iacomini, A. Cesario, B. Gui, V. Rufini, L. Boldrini, M. Gambacorta, G. Scambia, V. Valentini","doi":"10.1136/ijgc-2021-esgo.325","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.325","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123989925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"757 European Enhanced Recovery After Surgery (ERAS) gynecological oncology survey: current state of perioperative practice","authors":"N. Gómez-Hidalgo, A. Pletnev, Z. Razumova, N. Bizzarri, I. Selcuk, C. Theofanakis, K. Zalewski, T. Nikolova, M. Lanner, J. Kacperczyk-Bartnik, U. Acosta, PB Asuncion, A. Gil-Moreno, G. Nelson, C. Fotopoulou, JL Sánchez Iglesias","doi":"10.1136/ijgc-2021-esgo.317","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.317","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124762740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"421 Chemoembolization with HepaSphere in treatment of patients with primary and recurrent gynecological tumors","authors":"A. Kedrova, B. Alexander","doi":"10.1136/ijgc-2021-esgo.302","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.302","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130800663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"798 The lockdown effect on gynaecological cancer surgeries during the covid-19 pandemic","authors":"V. Theodoulidis, D. Vlachos, C. Theofanakis, V. Pergialiotis, N. Thomakos, A. Rodolakis, D. Haidopoulos","doi":"10.1136/ijgc-2021-esgo.318","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.318","url":null,"abstract":"798 Figure 1Gynecological cancer surgeries on both periods[Figure omitted. See PDF]Abstract 798 Table 1Type of procedures on both periodsConclusion*The findings of our study suggest that at the first wave of the pandemic lockdown, the operations conducted in our department did not alter. In accordance with international consensus guidelines the stage, the grade and the type of cancer, and the potential comorbidities were the main factors that accounted for the decision of the optimal mode of treatment.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133656363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}